-
5581
-
5582
-
5583
Tubular MYDGF Slows Progression of Chronic Kidney Disease by Maintaining Mitochondrial Homeostasis
Published 2025-01-01Get full text
Article -
5584
Lymphocyte Oxidative Stress/Genotoxic Effects Are Related to Serum IgG and IgA Levels in Coke Oven Workers
Published 2014-01-01Get full text
Article -
5585
FreshWater Watch: Investigating the Health of Freshwater Ecosystems, from the Bottom Up
Published 2025-01-01Get full text
Article -
5586
-
5587
-
5588
-
5589
-
5590
-
5591
-
5592
-
5593
Simultaneous Anti-Tuberculosis and Anti-Tumor Treatment with Immune Checkpoint Inhibitors for Co-Existent Pulmonary Tuberculosis and Advanced Lung Cancer
Published 2025-01-01“…Huaichong Wang,1 Liujie Gao,2 Xinjun Cai,1 Jinmeng Li,1 Yuying Lang,1 Ren Zheng,1 Shengya Yang3 1Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, People’s Republic of China; 2Department of Oncology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, People’s Republic of China; 3Tuberculosis Diagnosis and Treatment Center, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, People’s Republic of ChinaCorrespondence: Shengya Yang, Tuberculosis Diagnosis and Treatment Center, Hangzhou Red Cross Hospital, East Huancheng Road No. 208, Hangzhou, Zhejiang Province, People’s Republic of China, Email 15967116949@163.comBackground: Immune checkpoint inhibitors (ICIs) have emerged as the first-line treatment for driver-negative advanced non-small cell lung cancer (NSCLC). …”
Get full text
Article -
5594
-
5595
-
5596
-
5597
-
5598
-
5599
Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy
Published 2024-12-01Get full text
Article -
5600
Diagnostic Potential of Multidetector Computed Tomography for Characterizing Small Renal Masses
Published 2015-01-01Get full text
Article